Ageless WayLLC
Over 100 Advanced Health Nutrition Supplements
contact@agelessway.org
Verizon Cell (330) 414-7584
Fax (330) 865-9431
UPS Ground Orders Over $60.00 Ship Free
30 Day Guarantee
![]() |
JEUNESSE Inc.
Institute of Longevity Medicine 11/5/99
PRELIMINARY REPORT (additional
test results to follow)
Transfer Factor Testing
Background and rationale: Cancer is the second leading cause of death in the US. The rate of nearly every type of cancer is on the rise. Despite billions of dollars in research, the mortality rate has remained virtually unchanged since the 1960's using conventional treatments such as radiation, surgery, and chemotherapy. Thus, there is considerable interest in using immune modulation as an adjuvant for cancer therapy. Natural killer cells are particularly important in destroying cancer cells.
Purpose of study: To determine the in vitro anti-cancer effects of Transfer FactorΤ and Transfer Factor PlusΤ using PBMC isolated from human volunteers and assaying the increased ability of the NK cell population to kill K562 erythroleukemic cells.
Methods: 	1) PBMC killing of K562 (erythroleukemic) cells
Results:	2) Transfer Factor increased NK-cell killing by 103% and 		Transfer Factor PlusΤ by 248%
Conclusions: Transfer FactorΤ and Transfer Factor PlusΤ induced immune-based lysis of K562 cells at a level unprecedented in the director's experience or in the known medical literature. Since NK cell function is so crucial in killing cancer cells, these products are ideal candidates for cancer adjuvant therapy. In addition, NK cells form a first line of defense against infections from viruses and certain other microorganisms. Killing assays against K562 cells have also been correlated with increased activity against chronic and acute infections as well.
Darryl See, M.D.
Director, Bioassay Laboratory
Institute of Longevity Medicine
Huntington Beach, CA 92648
Transfer Factor Study
(4Life)
N.K. Assay, October 27, 1999
| Sample Name |
#of Live K562 Cells |
#of Dead K562 Cells |
Mean of Dead cells |
% Increase In Killing |
| Baseline - a |
95.8 |
42 |
||
| Baseline - b |
96.9 |
3.1 |
3.7 |
|
| Positive (PBMC) - a |
95.2 |
4.8 |
||
| Positive (PBMC) - b |
94.8 |
5.2 |
5.0 |
|
| Negative (Flour) - a |
94.2 |
5.8 |
||
| Negative (Flour) - b |
94.7 |
5.3 |
5.6 |
|
| Transfer Factor - a |
87.8 |
12.2 |
||
| Transfer Factor - b |
89.7 |
10.3 |
11.3 |
103% |
Transfer Factor Plus Study (4Life)
N.K. Assay	 November 4,1999
| Sample None |
#of Live K562 Cells |
#of Dead K562 Cells |
Mean of Dead cells |
% Increase In Killing |
| Baseline - a |
99 |
1.3 |
||
| Baseline - b |
98.1 |
1.9 |
1.6 |
|
| Positive (PBMC) - a |
95.8 |
42 |
||
| Positive (PBMC) - b |
97.1 |
2.9 |
3.6 |
|
| Negative (Flour) - a |
97.3 |
2.7 |
||
| Negative (Flow) - b |
96.6 |
3.4 |
3.1 |
|
| Transfer Factor Plus(200 m l) - a |
89.7 |
10.3 |
||
| Transfer Factor Plus(200 m l) - b |
69.1 |
10.9 |
10.6 |
248% |
| Transfer Factor Plus(20 m l) - a |
91.8 |
8.2 |
||
| Transfer Factor Plus(20 m l ) - b |
92.3 |
7.7 |
8.0 |
161% |
Transfer Factor and Transfer Factor Plus Study (4Life)
Toxicity Assay November 9, 1999
|
Sample |
Result |
|
Transfer Factor (2 mg) |
No toxicity observed |
|
Transfer Factor (200 m g) |
No toxicity observed |
|
Transfer Factor Plus (2 mg) |
No toxicity observed |
|
Transfer Factor Plus (200 m g) |
No toxicity observed |
Nutraceutical Induced
Increase in
Natural Killer Cell (NK) Activity
Purpose of Study: To determine the in vitro Natural Killer Cell (NK) activation effects of 4 Life Transfer Factor and Transfer Factor Plus using peripheral blood mononuclear cells (PBMC) isolated from human volunteers and assaying the increased ability of the NK cell population to kill K562 erthroleukemic cells.
Conclusions: 4Life Transfer
Factor and Transfer Factor Plus induced immune-based lysis (breakdown) of K562
cells at a level unprecedented in the director's experience or in any known
medical literature, Since NK cell function is so crucial in killing dangerous
Cells, these products are ideal candidates for human and animal immune support.
|
Nutraceutical Tested |
Percent (%) Rise in NK Cell Activity |
| 4Life Transfer Factor Plus |
248% |
| 4Life Transfer Factor |
103% |
| IP6 (highest of group Previously tested) |
49% |
| Plant Polysaccharide Formula |
48% |
| Echinacea |
47% |
| Shitake Mushroom |
42% |
| Cordecep Formula |
28% |
| Bovine Colostrum |
23% |
| Phytonutrient Formula with Garlic |
21% |
| Endocrine System Formula |
16% |
| Concentrate (acemannan) |
15% |
| Noni (Morinda citrafolia) |
15% |
Some of these products reflect an average of different brands.
Baseline activity is the measure of the unassisted ability of white blood cells to kill K562 leukemia (cancer) cells.
Natural Killer Cells are the body's first line of defense against cancers and viruses.
The increase in the ability of white blood cells to kill K562 cancer cells is directly related to the increase in Natural Killer Cell activity.
This study does not claim nor should it be interpreted to cure, prevent or mitigate any serious disease. The results have been reported as they were received. Seek advise from your health professional before beginning any new regimen
We have collected some services that complement our health nutritional supplements |
The Diet Solution
Stop dieting... Start eating... and Start living...
Learn the right way to eat...
Contains a lot of good free information...
Certified nutritionist and exercise physiologist...
Discover the #1 honest and natural diet and nutrition program on the internet ==> Click Here!Explore The Vast World Of Online Shopping
Great deals... Start a business... Almost anything you can think of...
Choice products online save you the money and the run-around...
Because quality of life matters ==> Click Here!